Healthcare Business Review

Advertise

with us

  • APAC
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Sections
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Service
    Facility Management Services
    Financial Services
    Healthcare Consulting
    Healthcare Digital Marketing
    Healthcare Education
    Healthcare Marketing
    Healthcare Procurement
    Healthcare Staffing
    Medical Staff Training and Development
    Medical Transportation
    Nurse Staffing
    Plastic Surgery
    Regenerative Medicine
    Therapy Services 
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Service
    Facility Management Services
    Financial Services
    Healthcare Consulting
    Healthcare Digital Marketing
    Healthcare Education
    Healthcare Marketing
    Healthcare Procurement
    Healthcare Staffing
    Medical Staff Training and Development
    Medical Transportation
    Nurse Staffing
    Plastic Surgery
    Regenerative Medicine
    Therapy Services 
  • CXO Insights
  • News
  • Vendor Viewpoint
  • Conferences
  • CXO Awards
×
#

Healthcare Business Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review

Subscribe

loading

Thank you for Subscribing to Healthcare Business Review Weekly Brief

  • Home
  • CXO Insights

Building a Culture of Accountability in the Healthcare Industry

Healthcare Business Review

Robert Fink, Vice President, Pharmacy Services, UofL Health
Tweet

Robert is an entrepreneurial senior healthcare executive with a demonstrated history of working in the hospital & health care industry. He is skilled in hospital pharmacy, 340b operations, pharmacotherapy, pharmacokinetics, parenteral nutrition, healthcare supply chain, consulting, imaging, laboratory services, and physical/occupational/speech therapies.


Please tell us about the journey that you've had so far and your roles and responsibilities at UofL Health.


I've been a pharmacist for 40 years and spent 25 years in pharmacy leadership at the corporate and national levels. During my tenure with a for-profit system in Nashville, I oversaw more than 200 hospitals spanning 38 states and five time zones. It was in this role that we developed and implemented robust policies, procedures, and controls for handling controlled substances, emphasizing surveillance and accountability. The methods and equipment we established have been tested and proven effective over nearly two decades.


In my current position, I hold responsibility for all pharmacy operations across our extensive system, encompassing eight hospitals with a combined total of 1700 beds. We have several freestanding emergency departments and surgery centers and employs over a thousand physicians, as well as 13,000 staff members. We have inpatient operations as well as outpatient operations ranging from retail to specialty pharmacy and infusion. Our team comprises over 300 pharmacy personnel, including 16 pharmacy residents.


I joined UofL during a pivotal period when we acquired seven hospitals and medical centers from CHI. Today we stand as the largest academic health system in the state. Our university hospital features a level one trauma center, a level three neonatal intensive care unit (NICU), the state's sole burn center, a stroke center, transplant services, and a substantial multi-site specialty cancer center that incorporates cutting-edge cell therapies.


What are some of the major challenges in the market when it comes to controlled substance accountability space?


Establishing a comprehensive interdisciplinary committee to assess potential issues in hospitals is a crucial yet challenging task. This responsibility should not solely rest on the shoulders of the pharmacy; instead, it demands executive leadership involvement from the CEO level throughout the organization. The organization needs to establish a culture of accountability and need to be ever vigilant. It's imperative to operate under the assumption that there could be potential problems, necessitating ongoing audits, monitoring, and a proactive approach to strengthen control measures continually.


“It is imperative to forge an interdisciplinary team, guided by the organization’s CEO, to cultivate a culture of accountability that resonates throughout the entire organization”


In our organization, we go beyond focusing solely on DEA controlled substances. We've identified a list of non-controlled substances, such as costly drugs like Botox, Sildenafil (Viagra), Propofol, Precedex, Flexeril, Toradol, and others, which we treat with the same level of scrutiny due to their potential for drug diversion. In addition, we monitor drugs that could be used as substitutes for controlled substances, such as evaluating Benadryl and other sedatives.


What are recent the trends or developments that have evolved in this industry?


The healthcare market appears to be relatively stable, with most hospitals incorporating automated dispensing equipment. It's advisable for those without an electronic narcotics vault to consider investing in such software for comprehensive monitoring of transactions, covering the entire process from ordering to administration. There have also been recent changes in the extra surveillance software market, with Bluesight acquiring Medacist, indicating some consolidation.


Typically, this added software is offered either by the automated dispensing cabinet vendor or through a third-party vendor. In our case, we integrate this software with our electronic medical record system and our HR information system, which includes our time and attendance system.


Is there a project initiative that you've been part of recently and have implemented one or couple of best practices to make that successful?


Our comprehensive system-wide program features 20 policies and procedures. We leverage Omnicell automation for our dispensing technology and have narc vaults or electronic control systems dispensing equipment for each of our hospitals to control access. We use Bluesight as our surveillance software. Our drug diversion reduction committee is an interdisciplinary committee that includes executive members like the Chief Nursing Officer, Chief Pharmacy Officer, and Chief Risk Management Officer. The pharmacy compliance department consists of a nurse auditor, a pharmacist manager, and a pharmacy technician analyst. The broader committee includes representatives from nursing, HR, an anesthesiologist and pharmacy leaders across the system that meet monthly to establish audit criteria, review results and maintain a dashboard. We perform over a hundred audits annually, with prompt reporting to relevant authorities like the DEA and state boards in the case of identified theft.


Maintaining a robust system not only acts as a deterrent but should also be complemented by strong HR policies and this includes incorporating drug testing measures.  For example, the inclusion of urine drug screens is essential, and the effectiveness is bolstered by incorporating random drug screens and also underscores the importance of implementing pre-employment drug screening as well. It is also crucial to foster awareness among the staff and maintain a culture of accountability to contribute significantly to serving as deterrents.


Any specific piece of advice that you'd like to share with your fellow peers or other industry leaders?


My advice is that it is crucial to establish an interdisciplinary team, with the organization's CEO at the helm, to foster a culture of accountability across the entire organization.


Weekly Brief

loading
> <
  • Current Issue
  • Current Issue
  • Current Issue
  • Ways to Avoid Sports Injury

    Julio Martinez, Medical Director, Baystate Health
  • Automating Medication Management for Better Outcomes

    James Trumble, Vice President of Clinical Integration, Peninsula Regional Medical Center
  • Technology's Role in Enhancing Patient Safety: Real-Time Monitoring, Error Reduction, and Decision-Making

    Betsy Reed, Director of Patient Safety, Good Samaritan Hospital
  • Environmental Regulations and the Path Ahead

    Paul Webering, MBA, CHFM, Vice President, National Jewish Health
  • The Application of Remote Monitoring technology in the Management of Heart Failure Patients

    Ugochukwu O. Egolum, MD, FACC, Chief, Department of Cardiology, Northeast Georgia Health System
  • Optimizing Healthcare Procurement and Supply Chain Management

    Cesar A. Román, Director of Strategic Sourcing and Procurement Operations, University Health
  • Navigating Quality, Safety, and Leadership in Healthcare

    Christina Huitt, sr. Director of Quality & Patient Safety, Caromont Health
  • The Safety Playbook: Building Resilient Teams and Improving System Design

    Alexandra Perreiter, Director of Patient Safety, Sharp HealthCare

Read Also

The Importance of Patient-first Approach To Innovation

The Importance of Patient-first Approach To Innovation

Dr. Aivee Teo, Founder, President and Medical Director, The Aivee Clinic
READ MORE
Combining Expertise Across Borders to Implement Equitable and Sustainable Precision Cancer

Combining Expertise Across Borders to Implement Equitable and Sustainable Precision Cancer

Kjetil Tasken, Head and Director of Institute of Cancer Research, Oslo University Hospital
READ MORE
Takeaways from Incorporating the Patient Experience as a Strategic Element and Enabler to Foster a Culture of Innovation through the Hospital

Takeaways from Incorporating the Patient Experience as a Strategic Element and Enabler to Foster a Culture of Innovation through the Hospital

Joan Vinyets i Rejón, Head of Patient Experience, Barcelona Children’s Hospital Sant Joan de Déu
READ MORE
Revolutionising patient education: How a Start-Up called HelloProfessor is changing the game

Revolutionising patient education: How a Start-Up called HelloProfessor is changing the game

Sophia Neisinger, Dermatology Resident & Head Digital Health Program, Charite
READ MORE
The Hidden Costs of Vendor Contracts: How Boilerplate Terms Can Undermine Hospital Budgets

The Hidden Costs of Vendor Contracts: How Boilerplate Terms Can Undermine Hospital Budgets

Cesar A. Roman, Director of Strategic Sourcing and Procurement Operations, University Health
READ MORE
The Rise of the Healthcare Innovator

The Rise of the Healthcare Innovator

Ryan Kerstein, Associate Medical Director for Innovation and Research, Buckinghamshire Healthcare NHS Trust
READ MORE

The Hidden Costs of Vendor Contracts: How Boilerplate Terms Can Undermine Hospital Budgets

Cesar A. Roman, Director of Strategic Sourcing and Procurement Operations, University Health

The Rise of the Healthcare Innovator

Ryan Kerstein, Associate Medical Director for Innovation and Research, Buckinghamshire Healthcare NHS Trust

Efficiently Implementing Preventative Maintenance Programs with Skilled Engineers

Mark Hornby, Medical Engineering Manager, Northern Care Alliance NHS Foundation Trust

Revolutionizing Podiatry for Efficient Patient Care

Ron Guberman, Director of Podiatric Medical Education and Co-Chief of the Podiatry Division, Wyckoff Heights Medical Center
Loading...
Copyright © 2025 Healthcare Business Review. All rights reserved. |  Subscribe |  Sitemap |  About us |  Newsletter |  Feedback Policy |  Editorial Policy follow on linkedin
CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://financial-service.healthcarebusinessreviewapac.com/cxoinsight/building-a-culture-of-accountability-in-the-healthcare-industry-nwid-2137.html